櫻井 宏明

Keyphrases

1. TAK1 100%
2. Phosphorylation 85%
3. NF-B 84%
4. Tumor Necrosis Factor-α 57%
5. Epidermal Growth Factor Receptor 50%
6. Nuclear factor-B 38%
7. Signaling Pathway 34%
8. Cancer Cells 32%
9. Induced Apoptosis 29%
10. Transforming Growth Factor-β 29%
11. Mitogen-activated Protein Kinase 26%
12. Metastasis 25%
13. Non-canonical 25%
14. Activator protein-1 (AP-1) 23%
15. Lymphatic Endothelial Cells 19%
16. TAK1-Binding Proteins 18%
17. Apoptosis 18%
18. In Cancer 18%
19. Inhibitory Effect 17%
20. Extracellular Signal-regulated Kinase 17%
21. TRAIL-induced Apoptosis 17%
22. Transcription Factor 16%
23. Induced Activation 16%
24. Protein Kinase 15%
25. Endocytosis 15%
26. P38 Mitogen-activated Protein Kinase (p38 MAPK) 15%
27. HeLa Cells 15%
28. Melanoma 15%
29. Colon 26 14%
30. C-Jun N-terminal Kinase 14%
31. Breast Cancer Cells 14%
32. Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) 14%
33. Kampo Medicine 13%
34. Tumor Growth 13%
35. Interleukin-1β 13%
36. Tumor Cells 12%
37. Antitumor Activity 12%
38. Glomerulonephritis 12%
39. TAB2 12%
40. Receptor Tyrosine Kinase 12%
41. Non-small Cell Lung Cancer (NSCLC) 12%
42. Plasma Proteins 12%
43. DNA Binding 11%
44. Melanoma Cells 11%
45. Epidermal Growth Factor Receptor Signaling 11%
46. Ubc13 11%
47. Human T-cell Leukemia Virus Type 1 (HTLV-1) 11%
48. Tyrosine Phosphorylation 11%
49. Gastric Cancer 11%
50. Juzentaihoto 11%